BONESUPPORT FORTIFY PATIENT ENROLLEMENT FINALIZED EARLIER THAN ORIGINAL PLAN
Lund, Sweden, 16.30 CET, 15 June 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the enrollment of the FORTIFY study on CERAMENT® G has been completed with 198 subjects enrolled. BONESUPPORT has recently requested a study protocol amendment to reduce the sample size by approximately 30 subjects due to anticipated enrolment challenges during the COVID-19 pandemic. A blinded sample size review by an independent clinical study statistician ensured that closing enrolment at 198 subjects has only a minimum impact on the